Physiological and behavioral effects of methamphetamine in a mouse model of endotoxemia: A preliminary study

Pharmacology Biochemistry and Behavior

Volumn 77, Issue 2, 2004, Pages 365-370

  Sánchez Alavez, Manuel ^a   Gombart, Lhys M ^a   Huitrón Reséndiz, Salvador ^a   Carr, Janai R ^a   Wills, Derek N ^a   Berg, Greta ^a   Campbell, Iain L ^a   Gauvin, David V ^b   Henriksen, Steven J ^a   Criado, José R ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b MPI RESEARCH   (United States)

Author keywords

Core body temperature; Hyperthermia; Lipopolysaccharide; Methamphetamine; Mice; Motor activity; Telemetry

Indexed keywords

LIPOPOLYSACCHARIDE; METHAMPHETAMINE; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DRUG EFFECT; ENDOTOXEMIA; EXPOSURE; FEMALE; HYPERTHERMIA; IMMUNE RESPONSE; MOTOR ACTIVITY; MOUSE; NEUROTOXICITY; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROVOCATION TEST; SENSITIZATION; STATISTICAL SIGNIFICANCE;

ANIMALIA;

EID: 1642493729     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2003.11.013     Document Type: Article

References (38)

1. Abekawa T., Ohmori T., Koyama T. Tolerance to the neurotoxic effect of methamphetamine in rats behaviorally sensitized to methamphetamine or amphetamine. Brain Res. 767:1997;34-44.
2. Albers D.S., Sonsalla P.K. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. J. Pharmacol. Exp. Ther. 275:1995;1104-1114.
3. Asanuma M., Cadet J.L. Methamphetamine-induced increase in striatal NF-kappaB DNA-binding activity is attenuated in superoxide dismutase transgenic mice. Brain Res. Mol. Brain Res. 60:1998;305-309.
4. Buonaguro L., Buonaguro F.M., Giraldo G., Ensoli B. The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure. J. Virol. 68:1994;2677-2682.
5. Cadet J.L., Ali S., Epstein C. Involvement of oxygen-based radicals in methamphetamine-induced neurotoxicity: evidence from the use of CuZnSOD transgenic mice. Ann. N.Y. Acad. Sci. 738:1994;388-391.
6. Castano A., Herrera A.J., Cano J., Machado A. Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system. J. Neurochem. 70:1998;1584-1592.
7. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann. N.Y. Acad. Sci. 933:2001;222-234.
8. Dantzer R.O., Kelley K.W. Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sci. 44:1989;1995-2008.
9. Davidson C., Gow A.J., Lee T.H., Ellinwood E.H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res. Rev. 36:2001;1-22.
10. Ensoli B., Buonaguro L., Barillari G., Fiorelli V., Gendelman R., Morgan P.A.et al. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67:1993;277-287.
11. Escubedo E., Guitart L., Sureda F.X., Jimenez A., Pubill D., Pallas M.et al. Microgliosis and down-regulation of adenosine transporter induced by methamphetamine in rats. Brain Res. 814:1998;120-126.
12. Flora G., Lee Y.W., Nath A., Hennig B., Maragos W., Toborek M. Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain. Exp. Neurol. 179:2003;60-70.
13. Fukumura M., Cappon G.D., Pu C., Broening H.W., Vorhees C.V. A single dose model of methamphetamine-induced neurotoxicity in rats: effects on neostriatal monoamines and glial fibrillary acidic protein. Brain Res. 806:1998;1-7.
14. Fumagalli F., Gainetdinov R.R., Wang Y.M., Valenzano K.J., Miller G.W., Caron M.G. Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. J. Neurosci. 19:1999;2424-2431.
15. Gao H.M., Jiang J., Wilson B., Zhang W.Q., Hong J.S., Liu B. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J. Neurochem. 81:2002;1285-1297.
16. Gayle D.A., Ling Z., Tong C., Landers T., Lipton J.W., Carvey P.M. Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-a, interleukin-β, and nitric oxide. Brain Res. Dev. Brain Res. 133:2002;27-35.
17. Kent S., Bluthe R.-M., Kelley K.W., Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol. Sci. 13:1992;24-28.
18. Kozak W., Conn C.A., Kluger M.J. Lipopolysaccharide induces fever and depresses locomotor activity in unrestrained mice. Am. J. Physiol. 266:1994;R125-R135.
19. Kruman I., Nath A., Mattson M.P. HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp. Neurol. 154:1998;276-288.
20. Laye S., Parnet P., Goujon E., Dantzer R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Mol. Brain Res. 27:1994;157-162.
21. Lee Y.W., Hennig B., Yao J., Toborek M. Methamphetamine induces AP-1 and NF-kappaB binding and transactivation in human brain endothelial cells. J. Neurosci. Res. 66:2001;583-591.
22. Liu B., Du L., Hong J.S. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia and superoxide generation. J. Pharmacol. Exp. Ther. 293:2000;607-617.
23. Liu B., Gao H.M., Wang J.H., Jeohn G.H., Cooper C.L., Hong J.S. Role of nitric oxide in inflammation-mediated neurodegeneration. Ann. N.Y. Acad. Sci. 962:2002;318-331.
24. Lu X., Bing G., Hagg T. Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats. Neuroscience. 97:2000;285-291.
25. Minghetti L., Levi G. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog. Neurobiol. 54:1998;99-125.
26. Nicolini A., Ajmone-Cat M.A., Bernardo A., Levi G., Minghetti L. Human immunodeficiency virus type-1 Tat protein induces nuclear factor (NF)-kappaB activation and oxidative stress in microglial cultures by independent mechanisms. J. Neurochem. 79:2001;713-716.
27. O'Callaghan J.P., Miller D.B. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270:1994;741-751.
28. Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Rev. 25:1997;192-216.
29. Pu C., Broening H.W., Vorhees C.V. Effect of methamphetamine on glutamate-positive neurons in the adult and developing rat somatosensory cortex. Synapse. 23:1996;328-334.
30. Saper C.B. Neurobiological basis of fever. Ann. N.Y. Acad. Sci. 856:1998;90-94.
31. Schmidt C.J., Gehlert D.R., Peat M.A., Sonsalla P.K., Hanson G.R., Wamsley J.K.et al. Studies on the mechanism of tolerance for methamphetamine. Brain Res. 343:1985;305-313.
32. Segal D., Kuczenski R. Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization. J. Pharmacol. Exp. Ther. 282:1997;561-573.
33. Segal D.S., Kuczenski R., O'Neil M.L., Melega W.P., Cho A.K. Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge. Neuropsychopharmacology. 2003;1730-1740.
34. Sheng P., Wang X.B., Ladenheim B., Epstein C., Cadet J.L. AP-1 DNA-binding activation by methamphetamine involves oxidative stress. Synapse. 24:1996;213-217.
35. Shi B., Raina J., Lorenzo A., Busciglio J., Gabuzda D. Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. J. Neurovirol. 4:1998;281-290.
36. Williams K.C., Hickey W.F. Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu. Rev. Neurosci. 25:2002;537-562.
37. Yamamoto B.K., Zhu W. The effects of methamphetamine on the production of free radicals and oxidative stress. J. Pharmacol. Exp. Ther. 287:1998;107-114.
38. Zetterstrom M., Sundgren-Andersson A.K., Ostlund P., Bartfai T. Delineation of the proinflammatory cytokine cascade in fever induction. Ann. N.Y. Acad. Sci. 856:1998;48-52.